Exelixis Inc. (NASDAQ: EXEL) kicked off on May 19, 2023, at the price of $19.83, up 0.30% from the previous trading day. During the day, the shares moved up to $19.96 and dropped to $19.76 before settling in for the closing price of $19.73. Over the past 52 weeks, EXEL has traded in a range of $14.87-$22.47.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 28.90% annually for the last half of the decade. While this was happening, its average annual earnings per share was recorded -21.60%. With a float of $315.46 million, this company’s outstanding shares have now reached $324.42 million.
In an organization with 1223 employees, it is important to assess its efficiency. In terms of profitability, gross margin is +96.41, operating margin of +12.51, and the pretax margin is +14.55.
Exelixis Inc. (EXEL) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Exelixis Inc. is 0.70%, while institutional ownership is 88.10%. The most recent insider transaction that took place on Apr 05, was worth 778,989. In this transaction EVP, General Counsel & Sec of this company sold 38,930 shares at a rate of $20.01, taking the stock ownership to the 582,435 shares. Before that another transaction happened on Mar 10, when Company’s Director sold 15,300 for $16.61, making the entire transaction worth $254,133. This insider now owns 317,467 shares in total.
Exelixis Inc. (EXEL) Latest Financial update
In the latest quarterly report, which was put into the public domain on 3/30/2023, the organization reported $0.12 earnings per share (EPS), lower than consensus estimate (set at $0.15) by -$0.03. This company achieved a net margin of +11.31 while generating a return on equity of 7.76. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.16 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -21.60% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 27.10% during the next five years compared to 2.60% growth over the previous five years of trading.
Exelixis Inc. (NASDAQ: EXEL) Trading Performance Indicators
Take a look at Exelixis Inc.’s (EXEL) current performance indicators. Last quarter, stock had a quick ratio of 4.90. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.86. Likewise, its price to free cash flow for the trailing twelve months is 24.23.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.47, a number that is poised to hit 0.14 in the next quarter and is forecasted to reach 0.91 in one year’s time.
Technical Analysis of Exelixis Inc. (EXEL)
Let’s dig in a bit further. During the last 5-days, its volume was 2.07 million. That was inferior than the volume of 3.0 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 84.05%. Additionally, its Average True Range was 0.46.
During the past 100 days, Exelixis Inc.’s (EXEL) raw stochastic average was set at 85.19%, which indicates a significant decrease from 88.19% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 21.13% in the past 14 days, which was lower than the 27.35% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $18.94, while its 200-day Moving Average is $17.54. However, in the short run, Exelixis Inc.’s stock first resistance to watch stands at $19.91. Second resistance stands at $20.04. The third major resistance level sits at $20.11. If the price goes on to break the first support level at $19.71, it is likely to go to the next support level at $19.64. The third support level lies at $19.51 if the price breaches the second support level.
Exelixis Inc. (NASDAQ: EXEL) Key Stats
The company with the Market Capitalisation of 6.42 billion has total of 325,600K Shares Outstanding. Its annual sales at the moment are 1,611 M in contrast with the sum of 182,280 K annual income. Company’s last quarter sales were recorded 408,790 K and last quarter income was 40,030 K.
